跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Allezal - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Allezal
Approved
STANDARD
Allezal
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
6872ff4adf4d15ce
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
6872ff4adf4d15ce
Drug Approval Philippines Name
Allezal
Product Name
Allezal
Registration Number
DRP-1317-08
Brand Name
Allezal
Generic Name
Cetirizine Dihydrochloride
Dosage Form
Oral Solution
Dosage Strength
1mg/mL
Manufacturer
Lloyd Laboratories, Inc.
Trader
Euro-Health Care Exponents, Inc.
Distributor
WeCare Pharma Corp.
Issuance Date
28 April 2022
Expiry Date
04 May 2027
Pharmacologic Category
Antihistamine (Piperazine Derivative)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
6872ff4adf4d15ce
Type
Standard
Back to Philippines FDA Approvals